AUPP891299A0 - New 6-membered cyclic compounds - Google Patents

New 6-membered cyclic compounds

Info

Publication number
AUPP891299A0
AUPP891299A0 AUPP8912A AUPP891299A AUPP891299A0 AU PP891299 A0 AUPP891299 A0 AU PP891299A0 AU PP8912 A AUPP8912 A AU PP8912A AU PP891299 A AUPP891299 A AU PP891299A AU PP891299 A0 AUPP891299 A0 AU PP891299A0
Authority
AU
Australia
Prior art keywords
new
membered cyclic
cyclic compounds
compounds
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP8912A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPP8912A priority Critical patent/AUPP891299A0/en
Publication of AUPP891299A0 publication Critical patent/AUPP891299A0/en
Priority to CNB008043035A priority patent/CN1170814C/zh
Priority to DE60015732T priority patent/DE60015732T2/de
Priority to AU23257/00A priority patent/AU766655B2/en
Priority to TR2001/02494T priority patent/TR200102494T2/xx
Priority to EP00902080A priority patent/EP1159258B1/en
Priority to JP2000602198A priority patent/JP4089159B2/ja
Priority to RU2001126120/04A priority patent/RU2211215C2/ru
Priority to ES00902080T priority patent/ES2226775T3/es
Priority to BR0010225-3A priority patent/BR0010225A/pt
Priority to KR1020017010325A priority patent/KR100620406B1/ko
Priority to DK00902080T priority patent/DK1159258T3/da
Priority to CA002371827A priority patent/CA2371827C/en
Priority to HU0200116A priority patent/HUP0200116A3/hu
Priority to AT00902080T priority patent/ATE282022T1/de
Priority to HK02106646.3A priority patent/HK1044934B/zh
Priority to PCT/JP2000/000601 priority patent/WO2000051970A1/en
Priority to PT00902080T priority patent/PT1159258E/pt
Priority to TW089102410A priority patent/TWI225856B/zh
Priority to ARP000100793A priority patent/AR029618A1/es
Priority to US10/285,526 priority patent/US6664293B2/en
Priority to US10/653,977 priority patent/US7037942B2/en
Priority to US11/269,612 priority patent/US7241811B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AUPP8912A 1999-02-26 1999-02-26 New 6-membered cyclic compounds Abandoned AUPP891299A0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
AUPP8912A AUPP891299A0 (en) 1999-02-26 1999-02-26 New 6-membered cyclic compounds
PT00902080T PT1159258E (pt) 1999-02-26 2000-02-03 Compostos de amida para a potenciacao da actividade colinergica
KR1020017010325A KR100620406B1 (ko) 1999-02-26 2000-02-03 콜린작용 활성을 강화시키기 위한 아미드 화합물
CA002371827A CA2371827C (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity
AU23257/00A AU766655B2 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity
TR2001/02494T TR200102494T2 (tr) 1999-02-26 2000-02-03 Kolinerjik aktivitenin güçlendirilmesi için amid bileşikleri.
EP00902080A EP1159258B1 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity
JP2000602198A JP4089159B2 (ja) 1999-02-26 2000-02-03 コリン作用活性の強化作用を有するアミド化合物
RU2001126120/04A RU2211215C2 (ru) 1999-02-26 2000-02-03 Амиды кислот, способ их получения и фармацевтическая композиция на их основе
ES00902080T ES2226775T3 (es) 1999-02-26 2000-02-03 Compuestos amidas para la potenciacion de actividad colinergica.
BR0010225-3A BR0010225A (pt) 1999-02-26 2000-02-03 Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso
CNB008043035A CN1170814C (zh) 1999-02-26 2000-02-03 用于强化胆碱能活性的酰胺化合物
DK00902080T DK1159258T3 (da) 1999-02-26 2000-02-03 Amidforbindelser til potensering af kolinerg aktivitet
DE60015732T DE60015732T2 (de) 1999-02-26 2000-02-03 Amidverbindungen zur stärkung der cholinergischen wirkung
HU0200116A HUP0200116A3 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity and pharmaceutical compositions containing them and process for the preparation of the compounds
AT00902080T ATE282022T1 (de) 1999-02-26 2000-02-03 Amidverbindungen zur stärkung der cholinergischen wirkung
HK02106646.3A HK1044934B (zh) 1999-02-26 2000-02-03 用於强化胆碱能活性的酰胺化合物
PCT/JP2000/000601 WO2000051970A1 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity
TW089102410A TWI225856B (en) 1999-02-26 2000-02-14 Amide compounds
ARP000100793A AR029618A1 (es) 1999-02-26 2000-02-24 Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos
US10/285,526 US6664293B2 (en) 1999-02-26 2002-11-01 Amide compounds for the potentiation of cholinergic activity
US10/653,977 US7037942B2 (en) 1999-02-26 2003-09-04 Amide compounds for the potentiation of cholinergic activity
US11/269,612 US7241811B2 (en) 1999-02-26 2005-11-09 Amide compounds for the potentiation of cholinergic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP8912A AUPP891299A0 (en) 1999-02-26 1999-02-26 New 6-membered cyclic compounds

Publications (1)

Publication Number Publication Date
AUPP891299A0 true AUPP891299A0 (en) 1999-03-25

Family

ID=3813111

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPP8912A Abandoned AUPP891299A0 (en) 1999-02-26 1999-02-26 New 6-membered cyclic compounds
AU23257/00A Ceased AU766655B2 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU23257/00A Ceased AU766655B2 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity

Country Status (19)

Country Link
EP (1) EP1159258B1 (enExample)
JP (1) JP4089159B2 (enExample)
KR (1) KR100620406B1 (enExample)
CN (1) CN1170814C (enExample)
AR (1) AR029618A1 (enExample)
AT (1) ATE282022T1 (enExample)
AU (2) AUPP891299A0 (enExample)
BR (1) BR0010225A (enExample)
CA (1) CA2371827C (enExample)
DE (1) DE60015732T2 (enExample)
DK (1) DK1159258T3 (enExample)
ES (1) ES2226775T3 (enExample)
HK (1) HK1044934B (enExample)
HU (1) HUP0200116A3 (enExample)
PT (1) PT1159258E (enExample)
RU (1) RU2211215C2 (enExample)
TR (1) TR200102494T2 (enExample)
TW (1) TWI225856B (enExample)
WO (1) WO2000051970A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1738800A (en) 1998-11-23 2000-06-13 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
ATE252386T1 (de) 1998-12-24 2003-11-15 Janssen Pharmaceutica Nv Galantamin-zusammensetzung mit gesteuerter freisetzung
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
AR035431A1 (es) 2001-02-13 2004-05-26 Aventis Pharma Gmbh 6,7,8,9-tetrahidro-5h-benzocicloheptenil aminas aciladas, un metodo para su sintesis, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos
PE20020856A1 (es) 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
CA2535036C (en) 2003-08-06 2015-11-24 Senomyx, Inc. Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
KR101387563B1 (ko) 2006-04-21 2014-04-25 세노믹스, 인코포레이티드 고효능의 조미용 향료를 포함하는 식품 조성물 및 이의 제조 방법
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AR075401A1 (es) 2009-02-13 2011-03-30 Sanofi Aventis Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento
JP2025066196A (ja) * 2022-03-14 2025-04-23 国立大学法人東北大学 認知機能改善剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8287M (enExample) * 1968-12-31 1970-11-09
US4797419A (en) * 1986-11-03 1989-01-10 Warner-Lambert Company Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
EP0306375A1 (fr) * 1987-08-07 1989-03-08 Synthelabo Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
JPH06107544A (ja) * 1992-09-29 1994-04-19 Taisho Pharmaceut Co Ltd コリン作動性神経不全の改善・治療薬
JPH06298732A (ja) * 1993-02-16 1994-10-25 Taisho Pharmaceut Co Ltd インドール誘導体

Also Published As

Publication number Publication date
JP2002538132A (ja) 2002-11-12
AR029618A1 (es) 2003-07-10
TR200102494T2 (tr) 2002-01-21
KR100620406B1 (ko) 2006-09-13
CN1170814C (zh) 2004-10-13
HK1044934A1 (en) 2002-11-08
CA2371827A1 (en) 2000-09-08
CA2371827C (en) 2008-06-10
TWI225856B (en) 2005-01-01
DK1159258T3 (da) 2005-02-14
PT1159258E (pt) 2005-02-28
JP4089159B2 (ja) 2008-05-28
CN1341095A (zh) 2002-03-20
ATE282022T1 (de) 2004-11-15
AU2325700A (en) 2000-09-21
HK1044934B (zh) 2005-06-03
HUP0200116A2 (hu) 2002-05-29
ES2226775T3 (es) 2005-04-01
EP1159258A1 (en) 2001-12-05
HUP0200116A3 (en) 2002-11-28
DE60015732T2 (de) 2005-03-31
AU766655B2 (en) 2003-10-23
EP1159258B1 (en) 2004-11-10
KR20010102140A (ko) 2001-11-15
BR0010225A (pt) 2002-01-22
DE60015732D1 (de) 2004-12-16
RU2211215C2 (ru) 2003-08-27
WO2000051970A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
AU2001241142A1 (en) Cyclic compounds
AU5413600A (en) Compounds
AU4145200A (en) Cyclic compounds and uses thereof
AU1278701A (en) Novel compounds
AU2919001A (en) Syringe
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AU6032100A (en) New compounds
AU1746401A (en) Compounds
AU3997700A (en) Anti-first-pass effect compounds
AUPP891299A0 (en) New 6-membered cyclic compounds
AU1541601A (en) Syringes
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU6550800A (en) Hepoxilin analogs
AU5787901A (en) Compound
AU3133400A (en) Syringe
AU6567400A (en) Substituted 2-imino-thiazolines
AU5119400A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU2288900A (en) Novel compounds
AU4156800A (en) Novel compounds
AU1871101A (en) Cyclic compound
AU6168900A (en) Compounds
AU6831100A (en) Substituted heterocyclybenzofuranes